Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Korean Journal of Internal Medicine|January 25, 2024
Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell LymphomasGa-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft modelJaya Lakshmi Thangaraj, Sung-Hoon Jung, Manh-Cuong Vo, et al.
Heliyon|March 25, 2024
Exploring cellular immunotherapy platforms in multiple myelomaManh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, et al.
Cellular & Molecular Immunology|May 13, 2021
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse modelJaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung-Hoon Jung, et al.
The Korean Journal of Internal Medicine|June 9, 2023
The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabineMihee Kim, TaeHyung Kim, Seo-Yeon Ahn, et al.
Leukemia Research|May 24, 2022
Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasmsTaeHyung Kim, Jae-Sook Ahn, Meong Hi Son, et al.
Pageof 7